Cognition Therapeutics Inc CGTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/21/24 EDT
2.28quote price arrow up+0.01 (+0.44%)
Volume
2,085
Close
2.27UNCH (UNCH)
Volume
145,248
52 week range
0.90 - 3.49
Loading...
  • Open2.12
  • Day High2.27
  • Day Low2.08
  • Prev Close2.27
  • 52 Week High3.49
  • 52 Week High Date06/16/23
  • 52 Week Low0.90
  • 52 Week Low Date11/22/23

Key Stats

  • Market Cap90.933M
  • Shares Out40.06M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change22.7

KEY STATS

  • Open2.12
  • Day High2.27
  • Day Low2.08
  • Prev Close2.27
  • 52 Week High3.49
  • 52 Week High Date06/16/23
  • 52 Week Low0.90
  • 52 Week Low Date11/22/23
  • Market Cap90.933M
  • Shares Out40.06M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change22.7

RATIOS/PROFITABILITY

  • EPS (TTM)-0.92
  • P/E (TTM)-2.48
  • Fwd P/E (NTM)-2.36
  • EBITDA (TTM)-55.751M
  • ROE (TTM)-89.00%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cognition Therapeutics Inc

 

Profile

MORE
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of small molecule therapeutics targeting age-related degenerative disorders of the central nervous system and retina. The Company is investigating its lead candidate CT1812 in clinical programs in Alzheimer's disease, dementia with Lewy bodies and dry age-related macular degeneration (dry AMD). Its lead product candidate, CT1812, is an investigational orally...
Jack Khattar
Non-Executive Independent Chairman of the Board
Lisa Ricciardi
President, Chief Executive Officer, Director
John Doyle
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Address
Suite 261, 2403 Sidney Street
Pittsburgh, PA
15203
United States

Top Peers

SYMBOLLASTCHG%CHG
PASG
Passage Bio Inc
1.28UNCHUNCH
ALRN
Aileron Therapeutics Inc
3.77UNCHUNCH
RLYB
Rallybio Corp
1.61UNCHUNCH
SLS
Sellas Life Sciences Group Inc
1.42UNCHUNCH
TPST
Tempest Therapeutics Inc
3.36UNCHUNCH